Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-10-28
1997-09-30
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 4, 530303, 424489, 424 43, A61K 3826, A61K 3802, C07K 500, C07K 700
Patent
active
056725817
ABSTRACT:
A method for treating a patient suffering from diabetes mellitus by delivering aerosolized insulin to the patient and a programmed, portable, hand-held device used in such treatment methodology is disclosed. Two basic types of drug delivery devices are disclosed for use in connection with the present invention. In accordance with the first type of device the insulin is contained within a low boiling point propellant which is held within a canister under pressure. In accordance with the second type of device the insulin is present within a container in solution and the solution is moved through a porous membrane to create an aerosolized formulation which is inhaled by the patient. In accordance with both devices a measured amount of insulin containing formulation is automatically released into the inspiratory flow path of a patient in response to information obtained from determining the inspiratory flow rate and inspiratory volume of a patient. The determination of values and release of drugs are carried out in real time. Reproducibly dosing of insulin to the patient is obtained by repeatedly providing for automatic release of insulin formulation at the same inspiratory flow rate and inspiratory volume. To maximize the efficiency of the delivery of the insulin formulation the formulation is released at an inspiratory flow rate in the range of from about 0.1 to about 2.0 liters/second and a measured inspiratory volume in the range of about 0.1 to about 0.8 liters.
REFERENCES:
patent: 3812854 (1974-05-01), Michaels et al.
patent: 3991304 (1976-11-01), Hillsman
patent: 4106503 (1978-08-01), Rosenthal et al.
patent: 4361401 (1982-11-01), Smith et al.
patent: 4604847 (1986-08-01), Moulding, Jr. et al.
patent: 4627432 (1986-12-01), Newell et al.
patent: 4677975 (1987-07-01), Edgar et al.
patent: 4686231 (1987-08-01), Bender et al.
patent: 4819629 (1989-04-01), Jonson et al.
patent: 4877989 (1989-10-01), Drews et al.
patent: 4926852 (1990-05-01), Zoltan et al.
patent: 4984158 (1991-01-01), Hillsman
patent: 5011678 (1991-04-01), Wang et al.
patent: 5167506 (1992-12-01), Kilis et al.
patent: 5364838 (1994-11-01), Rubsamen
patent: 5497944 (1996-03-01), Weston et al.
Colthorpe, P. et al., "The pharmacokinetics of Pulmonary-Delivered Insulin:A comparison of intratracheal and aerosol administration to the rabbit", 1992, Pharmaceutical Research, 9:764-768.
Elliott, R.B. et al., "Parenteral absorption of insulin from the lung in diabetic children", 1987, Aust. Paediatr. J. 23:293-297.
Kohler, D., "Aerosols for Systemic Treatment", 1990, Lung, Suppl.:677-684.
Lauber, B.L. et al., "Deposition, Clearance, and Effects in the Lung", Journal of Aerosol Medicine, 4:286.
Lauber, B.L. et al., "Preliminary Study of the Efficacy of insulin aerosol delivered by oral inhalation in diabetic patients," 1994, JAMA, 269:2106-2109.
Moses, A.C. et al., "Insulin administered intranasally as an insulin-bile salt aerosol-Effectiveness and Reproducibility in Normal and Diabetic Subjects", 1983, Diabetes, 32:1040-1047.
Newman, S.P. et al., "Deposition of pressurized aerosols in the human respiratory tract", 1981, Thorax, 36:52-55.
Newman, S.P. et al., "How should a pressurized .beta.-adrenergic bronchodilator be inhaled?", 1981, Eur. J. Respir. Dis. 62:3-21.
Newman, S.P. et al., "Deposition of pressurized suspension aerosols inhaled through extension devices", 1981, Am. Rev. Respir. Dis. 124:317-320.
Newman, S.P., "Deposition and Effects of Inhalation Aerosols", 1983.
Remington's Pharmaceutical Sciences, A.R. Gennaro, ed., 1985, Mack Publishing Co.
Salzman, R.,"Intranasal aerosolized insulin mixed-meal studies and long-term use in type 1 diabetes", 1985, New England Journal of Medicine, 213:1078-1084.
Wigley, F.M. et al., "Insulin across respiratory mucosae by aerosol delivery", 1971, Diabetes, 20:552-556.
Yoshida, H. et al., "Absorption of insulin delivered to rabbit trachea using aerosol dosage form", 1979, J. Pharmaceutical Sciences 68:670-671.
Lloyd Lester John
Rubsamen Reid M.
Aradigm Corporation
Bozicevic Karl
Davenport Avis M.
LandOfFree
Method of administration of insulin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of administration of insulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of administration of insulin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2256636